Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
House Speaker Mike Johnson is vowing to power forward on a key budget committee vote early next week, setting up a clash with ...
The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...
In his final two years with the Seattle Seahawks, Carroll took Kenneth Walker III in the second round of the 2022 Draft and ...
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the ...
Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...
Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $166 from $162 and keeps a Neutral rating on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback